Founded (2007) Quaestio GP (www.quaestiogp.com), a boutique management-consulting firm specializing in external innovation and strategic partnerships that expand product portfolios and enable new business creation within the life science industry. Provides consulting and interim executive services for corporate clients to accelerate innovation and business growth through adopting external innovation, global technology scouting and technical intelligence models. Also,
advises and provides interim executive services for startups, inventors, and entrepreneurs to enable accelerating the commercialization and enhancing the value of their intellectual property through developing and executing partnership strategies.

Selected for this new role by Pfizer management after Warner-Lambert acquisition based on successes in prior role with Complementary Medicine Quanterra portfolio. Was responsible for identifying and acquiring external technologies and products to achieve above-market growth for the $4B Consumer Healthcare business.
•Created and implemented the company's Technology Search Process, the first known organized external search initiative in the consumer healthcare industry. Set overall strategy, managed processes, led external growth teams and successfully secured novel products to expand portfolios. Initiated collaboration agreements with global partners resulting in new products projected to generate over $350 million. Led deal negotiations and contributed to every stage of the deal process. Supported diversified categories including Nicotine Replacement Therapies; Respiratory Health; Hair care; Gastrointestinal (GI) Health; Oral Cavity Health and Therapeutic Skin Care global portfolios a

Led R&D efforts to establish a new Complementary Medicines business unit. Developed and executed a fast-track commercialization strategy that led to acquire external candidates and the launch of seven, first known clinically studied, new products in two years under Quanterra brand.

Led Confectionery Innovation and Technology Section of Adams Confectionery (currently Mondelez), formerly owned by Pfizer.
•Designed and implemented a claims support strategy for the launch of Halls Zinc Defense, a new medicated confection, generating incremental net sales exceeding $50M
•Invented and developed novel materials with significant potential implications for the chewing gum industry
•Introduced new sensory attributes into confectionary products, generating several new product introductions